Alkyl Amines Chemicals Ltd

Price story Before the numbers, the tape. A stock price moves through four repeating seasons: a flat base (stage 1), an advance (2), a top (3), a decline (4). Where the price sits in that cycle frames everything below.

Alkyl Amines Chemicals Ltd trades at ₹1,827, in a confirmed uptrend and 4 weeks into that stage. That is +7.3% against its own 200-day average. It sits at 63% of a 52-week range of ₹1,278 to ₹2,151. On relative strength it has been ahead of the NIFTY 500 on a trailing-13-week view for 16 straight weeks.

Today the stock is in a confirmed uptrend — week 4 of stage 2, confirmed. At ₹1,827 it trades +7.3% versus its 200-day average and sits at 63% of its 52-week range (₹1,278–₹2,151).

Against the market, two honest reads. Cumulative: over the last 10.3 years the stock moved +1,317% while the NIFTY 500 moved +274% — ahead of the index over the full window. Recent form: on a trailing-13-week view the stock has been ahead for 16 straight weeks — the ribbon below is that same metric, week by week.

What would end the trend, mechanically: two Friday closes in a row below the 200-day line. That is the exit rule — no debates.

→ The trend is one thing; the bill is another. Are you paying up for it? Next: the P/E sits at the 56th percentile of its own range.

Valuation P/E is the price of ₹1 of annual profit: how many rupees the market pays for each rupee the company earns in a year.

Alkyl Amines Chemicals Ltd trades at 48.3× P/E, mid-range by its own standards (56th percentile). Its long-run median P/E is 43.2×, measured across 10.4 years of weekly readings. This places the multiple against the stock’s own record, and says nothing about what the business is worth.

Today's P/E of 48.3× is mid-range by its own standards (56th percentile), against a long-run median of 43.2× measured over 10.4 years of weekly readings. This is a comparison against the stock's own history — not a claim about what it is worth.

Why the multiple sits where it does: over the past year annual EPS moved +133.8% against a −19.0% price move — earnings outran the price, pushing the multiple DOWN its own range.

The price move, decomposed: over 5y, of the −13.5%/yr price move, ~+0.0%/yr came from earnings growth and ~−13.5 pp from the multiple (compressing); over 10y, of the +28.6%/yr price move, ~+14.2%/yr came from earnings growth and ~+14.4 pp from the multiple (expanding). The split is the honest approximate (price return minus earnings growth); it makes the rally itself visible instead of hiding it behind the percentile.

Put together: the multiple is unremarkable against its own past, so the story rests on the earnings line underneath it, not the multiple.

The PEG ratio and its quarterly curve, which only the second data source carries, are not drawn on this page: its two data sources do not share enough overlapping reported history to be compared. A figure nobody could check is not used to price growth — the gap is a decision, not missing data.

→ Cheap or dear rides on the earnings. Are they actually growing? Next: the fundamental stage — where the business sits in its arc, and how growth has compounded.

Stage: No read Every business sits somewhere on a fundamental arc, and this page names the spot before anything else. The last twelve quarters of revenue, profit and EPS growth — plus the return the business earns on its capital — are read as curves: Deteriorating (the curves are falling), Turning around (a trough has just formed and the last few quarters lift off it), Improving (the climb off the trough is sustained), Consistent (steadily positive with healthy returns), Topping out (still high but decelerating from the peak). When the curves genuinely disagree the read is Mixed; too little history is No read. CAGR (compound annual growth rate) is the smooth yearly pace that turns the starting value into the latest one — the fairest way to compare growth across different time spans. Read the columns together: if the 1-year number towers over the 10-year, recent growth is running hotter than the long-run trend. A dash means that window is not held, or the base year was a loss (where a growth rate is not meaningful).

Alkyl Amines Chemicals Ltd reads as no read on its fundamental arc. Under eight usable quarters on the growth trio — not enough history for an honest trajectory read. The read is built from 4 quarters across 1 curve, on partial evidence.

Why it matters: with too little history, an honest page says so instead of guessing a trajectory.

One or more growth curves carry a base-effect spike — a large year-on-year move off a near-zero or loss-making comparable quarter. Those spikes are capped before the classifier reads the trajectory, and shown pinned on the chart, so a single distorted quarter does not drive the stage call.

Return readings here are annual, not quarterly — read as level and direction only; they can confirm the growth curves but never drive the stage on their own.

Fewer than eight usable quarters on the growth curves — this page will not guess a trajectory from a stub of history.

→ The stage names the trajectory. Next: the revenue line that produces it, quarter by quarter.

4-Factor Sector Score

56.9/100 — rank 8 of 27 in Speciality Chemicals · 73% evidence confidence

Alkyl Amines Chemicals Ltd scores 56.9 out of 100 against the 27 companies it is compared with in Speciality Chemicals, ranking 8. Balanced evidence: keep at normal research priority and require another comparable period before raising conviction.

The four contributions add to the total exactly: 20.4 + 19.2 + 9.3 + 8 = 56.9. This is the SAME number shown on the sector comparison — it is computed once, for the whole peer set, and read here.

What would change it: The read weakens if profit growth turns negative or margin improvement reverses while sector-relative strength deteriorates.

Revenue Revenue is the top line: everything the company billed its customers in the period.

Alkyl Amines Chemicals Ltd reported ₹235 Cr of revenue in the Mar 20 quarter, −0.8% year on year. Over 10 years it has compounded at 16.6% a year. The last full year, FY20, came in at ₹993 Cr. The last four reported quarters add to ₹993 Cr.

Alkyl Amines Chemicals Ltd reported ₹235 Cr of revenue in the Mar 20 quarter, −0.8% year on year. Over 10 years it has compounded at 16.6% a year. The last full year, FY20, came in at ₹993 Cr. The last four reported quarters add to ₹993 Cr.

FY20 revenue came in at ₹993 Cr (+17.4% on the year), capping 10 years at 16.6% compound. The latest quarter (Mar 20) printed ₹235 Cr, −0.8% year on year.

Pace check: the last four quarters averaged +19.3% growth against the decade's 16.6% — the current year is running faster than its own long-run rate.

→ Revenue slipped — did margins hold as it scaled? Next: 29.0% this quarter (+13.0 pp YoY).

Operating margin Operating margin is what is left of every ₹100 of sales after running the business, before interest and tax. It is the cleanest read on pricing power and cost control.

Alkyl Amines Chemicals Ltd's operating margin is 29.0% in the Mar 20 quarter, +13.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 12 fiscal years the operating margin has ranged 11.0% to 26.0%. The current quarter is running above every full year in that window.

Alkyl Amines Chemicals Ltd's operating margin is 29.0% in the Mar 20 quarter, +13.0 percentage points against the same quarter a year ago. That is the widest this company has ever printed on a full-year basis. Across 12 fiscal years the operating margin has ranged 11.0% to 26.0%. The current quarter is running above every full year in that window.

The latest quarter's operating margin is 29.0%, +13.0 pp against the same quarter a year ago. Across 12 fiscal years the operating margin has ranged 11.0%–26.0%, and FY20's 26.0% is the top of that band — a record year.

Why the margin moved: operating margin went +12.6 pp year on year while gross margin went +13.7 pp — the gain came mostly from the gross line: input costs and pricing.

Worth repeating from the valuation section: cheap against its own history on record margins is not the same thing as cheap — a record margin flatters every ratio built on top of it.

→ Margins held — did that reach the bottom line? Next: profit +157.9% in the latest quarter.

Net profit Net profit is what survives every cost, interest and tax — the number EPS, dividends and book value all grow from.

Alkyl Amines Chemicals Ltd earned ₹49.0 Cr of net profit in the Mar 20 quarter, +157.9% year on year. It is the 4th consecutive quarter of growth. Full-year FY20 profit was ₹201 Cr. The 10-year compound rate is 31.5%. That is 20.9% of the quarter's revenue. The same quarter a year earlier earned ₹19.0 Cr.

Alkyl Amines Chemicals Ltd earned ₹49.0 Cr of net profit in the Mar 20 quarter, +157.9% year on year. It is the 4th consecutive quarter of growth. Full-year FY20 profit was ₹201 Cr. The 10-year compound rate is 31.5%. That is 20.9% of the quarter's revenue. The same quarter a year earlier earned ₹19.0 Cr.

Mar 20 profit was ₹49.0 Cr, +157.9% year on year — the 4th consecutive quarter of growth. On the full year, FY20 printed ₹201 Cr (+133.7%), and the 10-year compound rate is 31.5%.

Why profit moved: revenue contributed −0.8% and the margin +13.0 pp — the quarter was margin-led: most of the profit growth came from keeping more of each sale.

Pace comparison, last four quarters: profit +132.3% vs revenue +19.3%. Profit is growing faster than sales — fixed costs are being spread over a bigger base, and each extra rupee of revenue drops more to the bottom line.

→ Profit rose — but did the cash follow? Next: 123% of the last 3 years' profit arrived as cash.

Cash flow — the router The P&L says what was earned; the cash-flow statement says what actually arrived. Operating cash flow (CFO) against profit is the cleanest lie detector in the accounts.

Over the last 3 fiscal years 123% of Alkyl Amines Chemicals Ltd's reported profit arrived as operating cash — the cash follows the profit. In FY20 that was ₹188 Cr of operating cash against ₹201 Cr of profit. After ₹76.0 Cr of capital spending, ₹112 Cr was left as free cash.

FY20: operating cash of ₹188 Cr against reported profit of ₹201 Cr, leaving free cash of ₹112 Cr after ₹76.0 Cr of capital spending. Across the last 3 fiscal years the conversion rate is 123% of profit.

Cash-flow readings here are annual — that is the resolution our series carries, so this section moves once a year.

Why conversion sits at 123%: the cash cycle tightened 52 days between FY15 and FY20 — cash that used to wait in the cycle now reaches the bank sooner.

Router verdict: the bigger cash user is investment — capital spending ran 4.2× depreciation over three years, so the next section's job is to check what that build-out is buying.

→ So follow the cash to where it goes. Next: ₹279 Cr of building over 3 years.

Where the cash goes Working capital is the cash tied up between paying suppliers and getting paid: debtor days (customers owe), inventory days (stock waits), and the cash conversion cycle (the whole loop, in days of sales).

Alkyl Amines Chemicals Ltd's cash conversion cycle runs 71 days in FY20, down from 123 days in FY15. Capital spending ran ₹279 Cr over the last 3 years. At FY20 sales of ₹993 Cr each day of that cycle holds about ₹2.7 Cr, so roughly ₹193 Cr sits inside the business at any moment.

FY20: debtors at 60 days, inventory at 67 days — roughly 2.2 months of stock waiting to sell; that is where the cash sits while it waits — for a full cycle of 71 days, tighter than FY15's 123.

The full loop: cash goes out to suppliers and production on day 0; stock waits 67 days to sell; customers pay about 60 days after that; and suppliers themselves are paid at 57 days — netting out to the 71-day cycle.

In money terms: at FY20 sales of ₹993 Cr, each day of the cycle holds about ₹2.7 Cr — so the 71-day loop keeps roughly ₹193 Cr sitting inside the business at any moment.

On the investment side: capital spending of ₹279 Cr over the last 3 fiscal years against ₹66.0 Cr of depreciation — the company is building well ahead of wear-and-tear. Capital work-in-progress stands at ₹45.0 Cr (FY20) — capacity paid for but not yet earning.

The synthesis: the cash is going into capacity, not disappearing into the cycle — the question becomes whether the new capacity earns.

→ Does all this activity actually earn its cost of capital? Next: ROCE is 41% and the ROIC − WACC spread is +0.5 pp.

Return on capital Return on capital employed (ROCE) is the profit the whole business earns on all the money in it — equity and debt together. It is the single best test of whether growth creates value or just size.⚠ unverified

Alkyl Amines Chemicals Ltd earns a ROCE of 41% in FY20. That is up from a trough of 11% in FY09. Return on invested capital clears the cost of that capital by +0.5 percentage points, so growth here adds value rather than only size. The wiring behind it is 20.2% net margin on 1.27× asset turns.

FY20 ROCE is 41%, recovered from a FY09 trough of 11% — the full ladder below shows the fall and the climb, undoctored.

Why the return is what it is — the wiring (FY20): 20.2% net margin × 1.27× asset turns × 1.46× balance-sheet leverage ≈ 37.5% on equity. Margin is doing the heavy lifting; leverage is modest — this is an earned return, not a borrowed one.

The capstone test — ROIC − WACC: 12.5% − 12.0% = a +0.5 pp spread. The 12.0% is a standing assumption for the cost of capital in India, not a per-stock estimate — read the sign and the size of the spread, not the decimals. Positive but thin — value creation with little room for error.

→ Returns like these — is the balance sheet borrowing to make them? Next: debt-to-equity is 0.16.

Debt Debt-to-equity says how much of the business is funded by borrowings. Low is the safe corner; the trend matters as much as the level.⚠ unverified

Alkyl Amines Chemicals Ltd carries total debt of ₹1.0 Cr against shareholder equity of ₹1,533 Cr as of Mar 26, a debt-to-equity of 0.00 — effectively unlevered. On the annual view that ratio went from 0.06 in FY21 to 0.00 in FY26. The returns elsewhere on this page are therefore earned rather than borrowed.

Mar 26: total debt of ₹1.0 Cr against shareholder equity of ₹1,533 Cr — a debt-to-equity of 0.00. On the annual view, debt-to-equity went from 0.06 (FY21) to 0.00 (FY26). The returns on this page are earned, not borrowed.

→ Who owns this, and are they adding or leaving? Next: Domestic institutions added 2.0 points over 8 quarters.

Ownership Who owns the stock, quarter by quarter: promoters (the controlling owners), foreign and domestic institutions, and the public. Steady accumulation by people close to the numbers is a signal; a quiet register is also an answer.

Domestic institutions added 2.0 points of Alkyl Amines Chemicals Ltd over 8 quarters, the biggest move on the register. That takes domestic institutions to 3.1% of the company. Foreign institutions moved +0.4 points over the same window, to 3.5%. The register is read on the four disclosed classes only; nothing is inferred between filings.

The register over the last two years — Domestic institutions: +2.0 points over 8 quarters to 3.1%; Foreign institutions: +0.4 points over 8 quarters to 3.5%; Promoters: +0.1 points over 8 quarters to 72.0%.

Why the register moved: domestic institutions drove it (+2.0 points) — steady accumulation by institutions reading the same numbers this page reads.

→ One last check: does the safety math agree? Next: the balance-sheet safety line.

Safety line The Z-score estimates how far a company sits from balance-sheet distress — above roughly 3 is safe, below roughly 1.8 is the danger zone. It was built for manufacturers, so it is not applied to banks and lenders.

Alkyl Amines Chemicals Ltd: the Z-score reads 18.00. A Z-score above roughly 3 reads as safe and below roughly 1.8 as the distress zone, so this sits well clear of distress. It is a distance-to-distress estimate from the balance sheet, not a forecast of failure.

Why it matters: a Z-score of 18.00 sits well clear of the distress zone — the balance sheet is not the risk here.

The safety line in one sentence: the Z-score reads 18.00.

Frequently asked questions